scPharmaceuticals Inc. (SCPH)
5.67
0.00 (0.00%)
Inactive · Last trade price on Oct 6, 2025

scPharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for scPharmaceuticals stock had an average target of 12, with a low estimate of 6.00 and a high estimate of 18.

Price Target: $12 (+111.64%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$6.00$12$18$18
Change+5.82%+111.64%+217.46%+217.46%
* Price targets were last updated on Aug 26, 2025.

Analyst Ratings

The average analyst rating for scPharmaceuticals stock from 3 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy333111
Buy000000
Hold000222
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Hold
Downgrades
$6
HoldDowngrades$6+5.82%Aug 26, 2025
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 25, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$20$12
Strong BuyMaintains$20$12+111.64%Mar 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong BuyReiterates$18+217.46%Mar 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong BuyReiterates$18+217.46%Mar 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
74.23M
from 36.33M
Increased by 104.30%
Revenue Next Year
130.68M
from 74.23M
Increased by 76.06%
EPS This Year
-1.11
from -1.91
EPS Next Year
-0.16
from -1.11
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---13.59M36.33M74.23M130.68M
Revenue Growth
----167.29%104.30%76.06%
EPS
-1.31-1.02-1.30-1.42-1.91-1.11-0.16
EPS Growth
-------
Forward PE
-------
No. Analysts
-----66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High78.8M157.5M
Avg74.2M130.7M
Low69.6M117.2M

Revenue Growth

Revenue Growth20252026202720282029
High
116.8%
112.2%
Avg
104.3%
76.1%
Low
91.5%
57.9%

EPS Forecast

EPS20252026202720282029
High-1.100.21
Avg-1.11-0.16
Low-1.10-0.33

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.